Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer	Disease Attributes, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, germinoma, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, seminoma, testicular cancer, testicular disorder	Active, not recruiting	Phase 3	2025-12-02		NCT02341989

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Haukeland University Hospital	163
Karolinska Institutet	493
Norrlands University Hospital	8
Oslo University Hospital	327
Sahlgrenska University Hospital	158
Skane University Hospital	71
St. Olavs Hospital	167
University Hospital of North Norway	93
University Hospital, Linkoeping	50
Uppsala University Hospital	80

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Institutt for kreftforskning og molekylær medisin, St Olavs Hospital	Trondheim	Norway	1
St. Olavs University hospital HF	Trondheim	Norway	1